Summary

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Medical Director to join our Cardiovascular/Renal/Metabolism team supporting our Clinical Development Unit. In this role, you will serve as Medical Lead for clinical trials and are responsible for the design of clinical study concepts leading to clinical trial protocols and oversight of studies, while collaborating with cross-functional stakeholders. This role requires a high-performing and highly passionate physician scientist who serves as a clinical role model for the team and demonstrates outstanding clinical scientific knowledge applicable to clinical research.

Job description

Build our future together

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Medical Director to join our Cardiovascular/Renal/Metabolism team supporting our Clinical Development Unit. In this role, you will serve as Medical Lead for clinical trials and are responsible for the design of clinical study concepts leading to clinical trial protocols and oversight of studies, while collaborating with cross-functional stakeholders. This role requires a high-performing and highly passionate physician scientist who serves as a clinical role model for the team and demonstrates outstanding clinical scientific knowledge applicable to clinical research.

This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.

When & where

Location: Tarrytown, NY
Travel: 10% to relevant conferences

Discover your role

You guide the Global Clinical Study Team to deliver high-quality trials on time.
You oversee the medical monitoring of clinical trials to ensure patient safety and adherence to regulatory guidance
You lead clinical study and protocol development and present to internal and external stakeholders.
You provide clinical and scientific leadership for data review, study reports, and publications.
You work closely with cross-functional partners to advance program goals and key deliverables.
You collaborate with discovery teams to help shape future targets and development opportunities in the field.

This role requires

An M.D. or equivalent with board eligibility or board certification in Cardiology, Nephrology, or Neurology (Autonomic specialists) strongly preferred; relevant experience can be acceptable.
At least 2 years pharmaceutical industry experience (equivalent research in academia will be considered)
Previous interactions with regulatory agencies or common technical document (CTD or “dossier”) submission in an ICH region is an advantage

Requirements

An M.D. or equivalent with board eligibility or board certification in Cardiology, Nephrology, or Neurology (Autonomic specialists) strongly preferred; relevant experience can be acceptable.
At least 2 years pharmaceutical industry experience (equivalent research in academia will be considered)
Previous interactions with regulatory agencies or common technical document (CTD or “dossier”) submission in an ICH region is an advantage

Benefits

Annual bonuses
Incentive plans
Equity awards
Pension or retirement benefits
401(k) company match
Health and wellness programs
Fitness centers
Medical insurance
Dental insurance
Vision insurance
Life insurance
Disability insurance
Paid time off
Family support benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.